BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 3141236)

  • 1. Metabolic effects of low-dose insulin therapy on glucose metabolism in diabetic ketoacidosis.
    Luzi L; Barrett EJ; Groop LC; Ferrannini E; DeFronzo RA
    Diabetes; 1988 Nov; 37(11):1470-7. PubMed ID: 3141236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy.
    Yki-Järvinen H; Koivisto VA
    J Clin Endocrinol Metab; 1984 Sep; 59(3):371-8. PubMed ID: 6430945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of hepatic insulin action in obese type 2 diabetic patients.
    Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
    Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance: a universal finding in diabetic states.
    Defronzo RA; Simonson D; Ferrannini E; Barrett E
    Bull Schweiz Akad Med Wiss; 1981-1982; ():223-38. PubMed ID: 6820936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients.
    Simonson DC; Delprato S; Castellino P; Groop L; DeFronzo RA
    Diabetes; 1987 Feb; 36(2):136-46. PubMed ID: 3100365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of insulin therapy on hepatic and peripheral insulin sensitivity in Type 2 (non-insulin-dependent) diabetes.
    Nankervis A; Proietto J; Aitken P; Harewood M; Alford F
    Diabetologia; 1982 Oct; 23(4):320-5. PubMed ID: 6754516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic effects of insulin in a human model of ketoacidosis combining exposure to lipopolysaccharide and insulin deficiency: a randomised, controlled, crossover study in individuals with type 1 diabetes.
    Svart MV; Rittig N; Kampmann U; Voss TS; Møller N; Jessen N
    Diabetologia; 2017 Jul; 60(7):1197-1206. PubMed ID: 28389705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
    Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A
    Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired insulin action in newly diagnosed type 1 (insulin-dependent) diabetes mellitus.
    Nankervis A; Proietto J; Aitken P; Alford F
    Diabetologia; 1984 Nov; 27(5):497-503. PubMed ID: 6391994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of diabetic ketoacidosis using normalization of blood 3-hydroxybutyrate concentration as the endpoint of emergency management. A randomized controlled study.
    Wiggam MI; O'Kane MJ; Harper R; Atkinson AB; Hadden DR; Trimble ER; Bell PM
    Diabetes Care; 1997 Sep; 20(9):1347-52. PubMed ID: 9283776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is a priming dose of insulin necessary in a low-dose insulin protocol for the treatment of diabetic ketoacidosis?
    Kitabchi AE; Murphy MB; Spencer J; Matteri R; Karas J
    Diabetes Care; 2008 Nov; 31(11):2081-5. PubMed ID: 18694978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance in diabetic ketoacidosis.
    Barrett EJ; DeFronzo RA; Bevilacqua S; Ferrannini E
    Diabetes; 1982 Oct; 31(10):923-8. PubMed ID: 6818069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of pulsatile versus continuous insulin administration on hepatic glucose production and glucose utilization in type I diabetic humans.
    Bratusch-Marrain PR; Komjati M; Waldhäusl WK
    Diabetes; 1986 Aug; 35(8):922-6. PubMed ID: 3525288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake.
    Nielsen MF; Basu R; Wise S; Caumo A; Cobelli C; Rizza RA
    Diabetes; 1998 Nov; 47(11):1735-47. PubMed ID: 9792543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes.
    Yki-Järvinen H; Koivisto VA
    J Clin Endocrinol Metab; 1984 Apr; 58(4):659-66. PubMed ID: 6365945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ketone bodies on glucose production and utilization in the miniature pig.
    Müller MJ; Paschen U; Seitz HJ
    J Clin Invest; 1984 Jul; 74(1):249-61. PubMed ID: 6376544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of efficacy of human and porcine insulin in treatment of diabetic ketoacidosis.
    Storms FE; Lutterman JA; van't Laar A
    Diabetes Care; 1987; 10(1):49-55. PubMed ID: 3105986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term fasting is a mechanism for the development of euglycemic ketoacidosis during periods of insulin deficiency.
    Burge MR; Hardy KJ; Schade DS
    J Clin Endocrinol Metab; 1993 May; 76(5):1192-8. PubMed ID: 8496310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic insulin action in adolescents with insulin-dependent diabetes mellitus: relationship with long-term glycemic control.
    Arslanian S; Heil BV; Kalhan SC
    Metabolism; 1993 Mar; 42(3):283-90. PubMed ID: 8487645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.